In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth to tenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing and ageing population represents a substantial commercial opportunity for drugmakers, although its controversial compulsory licensing scheme is deterring foreign investment, as is its political instability.
Additionally, the local operating environment is considered to be negative from the point of view of foreign research-based companies, due to a lack of data exclusivity, rife counterfeiting and parallel importation, compounded by the introduction of health economics in the approval of patented drugs.
However, prospects for patent law reform are improving, as a result of Thailand’s involvement in regional harmonisation initiative and the resumption of talks with the US over a free trade agreement (FTA).
Nevertheless – and despite the currently low per capita spending on medicines – Thailand’s pharmaceutical market is expected to perform better than most of its regional peers, as global economic downturn continues to stifle development. The market was worth THB120.4bn (US$3.53bn) in 2008, and is expected to post a year-on-year (y-o-y) growth of 7.67% in local currency terms for 2009. By 2014, the value is projected to have topped THB186bn (US$6.64bn), growing at a compound annual growth rate (CAGR) of 7.50% and 11.89% in local currency and US dollar terms, respectively, as the former appreciates against the latter. However, we must caution that there are significant risks to this optimistic forecast, primarily political instability.
In fact, political woes are expected to continue to hamper economic development. Given the depths of the fault lines between the two opposed political camps in Thailand, we expect progress on resolving the situation to be slow. Consequently, we expect gross domestic fixed capital formation growth to average 3.5% for the coming years, as investor sentiment is weighed down by political unrest. As such, we are projecting real GDP growth to average at below-trend 3.2% (a level below Thailand’s potential) over the next decade, which will also weigh down on progress in the field of healthcare modernisation, given the reliance on public funding in this area.
While there were few major industry and company news in the past few months, it has been reported that phase III clinical trials of an HIV vaccine – a prime-boost combination of AIDSVAX B/E, originally developed by VaxGen, and Sanofi Pasteur’s ALVAC HIV – resulted in significant lowering of HIV infection rates. The clinical study, executed by the Thai Ministry of Public Health with assistance from local and US-based researchers, was carried out on over 16,000 adult volunteers in Thailand. The positive results are highly significant, as this is the first time a prophylactic agent has shown efficacy against HIV.
Bangkok 7th World Most connected city to China
Bangkok also ranks 3rd in terms of the volume of Chinese corporate leasing activity over the last three years, according to a new report from real estate consulting firm JLL.
While China’s biggest corporates are increasingly flexing their global muscle as the country’s economic and geopolitical influence accelerates, Bangkok is the 10th most popular destination for mainland firms expanding overseas. (more…)
Thailand’s Special Economic Zones (SEZ) and new opportunity connected
The SEZ policy was first launched in 2015 based on the government’s belief in the strong potential of the 10 areas to connect with the neighboring countries in terms of trade, economy and investment
With its strategic location in the center of ASEAN with emerging markets, including Cambodia, Laos, Myanmar, Malaysia and southern China, on its border, Thailand is well position to connect investors to new opportunities arising from the increasing border trade and the region’s rapid economic growth.
Decrypting the Crypto Bubble : China Ban Vs. Thailand’s cautious welcome
ICO has gained popularity among tech startups as a convenient and timely way to access funding. In the past few months, ICO has grown exponentially and has surpassed early stage venture capital funding
Thailand Ecommerce Market: Shooting For Success
At present, the Thai ecommerce market is valued at USD 3.5 billion. According to a Google Temasek study, Thailand’s e-commerce...
Aspire Set to Become First SME Neobank in Southeast Asia with US$32.5 Million Raise
The recent financing has been led by Mass-Mutual Ventures Southeast Asia with participation from Silicon Valley’s Arc Labs and existing...
How is Thailand Bringing Technology to the Table?
In Asia, a country like Thailand has taken the initiative to implement agricultural biotechnology in its industry. The country has...